Johnson & Johnson is splitting into two companies, separating the division that sells BandAids and Listerine from its medical device and prescription drug business. The company said Friday that the division selling prescription drugs and medical devices will keep the Johnson & Johnson name. The new consumer health company will house brands including Neutrogena, Aveeno, Tylenol, Listerine, Johnsons, and BandAid. Company leaders told analysts that the move will make each business more nimble in adapting to their respective markets. It also allows for a more precise allocation of capital. Johnson & Johnson expects the split to occur in the next two years.
from Top Business News- News18.com https://ift.tt/3cckvVy
via IFTTT
Subscribe to:
Post Comments (Atom)
-
Theyve endured a financial crisis. Two deep recessions. Mounds of student debt. Stagnant pay. Costly health care. Dim job prospects. from ...
-
Krsnaa Diagnostics IPO Allotment: Investors can check the share allotment status in two ways a) via BSE b) via registrar’s website from To...
-
....क्योंकि पढ़ाई के लिए महंगी कीमत चुकानी पड़ती है... यहां के बच्चों को बाघों के इलाके में पढ़ने लिए हर... from आज तक https://ift.tt/2Ec...
No comments:
Post a Comment